Insider Transactions in Q1 2025 at West Pharmaceutical Services Inc (WST)
Insider Transaction List (Q1 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 18
2025
|
Bernard Birkett Sr VP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
272
-1.78%
|
$57,392
$211.0 P/Share
|
Feb 18
2025
|
Bernard Birkett Sr VP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
903
+5.42%
|
$190,533
$211.0 P/Share
|
Feb 18
2025
|
Cindy Reiss Clark Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
83
-1.62%
|
$17,513
$211.0 P/Share
|
Feb 18
2025
|
Cindy Reiss Clark Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
246
+4.58%
|
$51,906
$211.0 P/Share
|
Feb 18
2025
|
Chad Winters VP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
27
-1.94%
|
$5,697
$211.0 P/Share
|
Feb 18
2025
|
Chad Winters VP, Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
82
+5.57%
|
$17,302
$211.0 P/Share
|
Feb 18
2025
|
Annette F Favorite Sr. VP & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
83
-1.22%
|
$17,513
$211.0 P/Share
|
Feb 18
2025
|
Annette F Favorite Sr. VP & Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
246
+3.48%
|
$51,906
$211.0 P/Share
|
Feb 18
2025
|
Kimberly Banks Mac Kay SVP, GC & Corporate Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
92
-5.74%
|
$19,412
$211.0 P/Share
|
Feb 18
2025
|
Kimberly Banks Mac Kay SVP, GC & Corporate Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
246
+13.3%
|
$51,906
$211.0 P/Share
|
Feb 18
2025
|
Eric Mark Green President, CEO and Board Chair |
SELL
Payment of exercise price or tax liability
|
Direct |
700
-0.41%
|
$147,700
$211.0 P/Share
|
Feb 18
2025
|
Eric Mark Green President, CEO and Board Chair |
BUY
Exercise of conversion of derivative security
|
Direct |
2,460
+1.42%
|
$519,060
$211.0 P/Share
|
Feb 18
2025
|
Charles Witherspoon VP & Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
23
-1.75%
|
$4,853
$211.0 P/Share
|
Feb 18
2025
|
Charles Witherspoon VP & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
65
+4.7%
|
$13,715
$211.0 P/Share
|